EVO

AS OF

Dec 26, 04:59 PM (EDT)

Price

$3.12

Change

-$0.01 (-0.32%)

Capitalization

1.13B

96 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

EVO

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Evotec SE (EVO) Ownership - Who owns Evotec SE?

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

Essener Bogen 7

Phone

+49 40560810

Employees

4952

Web

https://www.evotec.com

Details

Group

Domestic Stock Funds

Fundamentals

EVO

Capitalization

1.13B

P/E Ratio

N/A

Risk (Beta)

2.16

Dividend Yield

N/A

Total Cash

243M

Total Cash/Share

0.68

Total Debt

96.9M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

2.51%

Revenue

756M

ROE

N/A

Book Value

800M

P/B Ratio

1.18

Cash Flow

N/A

Earnings

-0.45

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

178M

Current Ratio

2.12

Current Revenue Per Employee

34386.70

Dividends Per Share - Security

N/A

EBITDA

-116.99M

Float

N/A

Float - Current

N/A

Gross Income Margin

-0.04

Revenue To Assets

-8.45

Shares Held By Institutions

46.4M

Shares Outstanding - Current

355M

Total Liabilities

973M

Total Volume MTD

N/A

Value

-1

Gain YTD

-24.760

View a ticker or compare two or three

Compare

EVO

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EVO showed earnings on November 05, 2025. You can read more about the earnings report here.

View AI-Driven Trading for EVO

A.I. Advisor

published General Information

General Information

Industry PharmaceuticalsGeneric